A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants
Clinical trial NCT04905043 · COMPLETED
Trial details
- NCT number
- NCT04905043
- Sponsor
- Acerta Pharma BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-03
- Primary completion
- 2016-07-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.